Browsing: SRS

Abstract results from the TURBO-NSCLC study found that patients who received upfront SRS in addition to CNS-penetrant TKI for EGFR…

Top Line: Is salvage SRS effective for recurrent grade 2 and 3 meningioma?The Study: Recurrent grade 2 and 3 meningiomas…

Last year, the V-REX trial found that upfront SRS for vestibular schwannoma resulted in better tumor volume control compared to…

This retrospective study found that both the number of brain metastases and total volume of brain metastases has a significant…

Top Line: What is the risk of hypopituitarism after SRS for nonfunctioning pituitary tumors?The Study: This large, multicenter retrospective study…

In the PERMEATE trial, the combination of pyrotinib (a small molecule TKI that targets HER1, ERBB2, and HER4) and capecitabine…

Top Line: Do antibody drug conjugates increase the risk of radiation necrosis for patients receiving SRS for brain mets?The Study:…

Top Line: What is the intracranial activity of chemoimmunotherapy for untreated NSCLC brain metastases? The Study: Systemic therapy won’t be…

Top Line:Tucatinib is increasingly used as part of combination systemic therapy for metastatic HER2+ breast cancer with impressive intracranial activity.…